Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: Roche-Holding-AG

SWISS-HEALTH/
RTX2V63E
December 15, 2016
The office tower of the headquarters of Swiss drugmaker Roche is seen in Basel, Switzerland, December...
Basel, Switzerland
The office tower of the headquarters of Swiss drugmaker Roche is seen in Basel
The office tower of the headquarters of Swiss drugmaker Roche is seen in Basel, Switzerland, December 15, 2016. REUTERS/Arnd Wiegmann
SWISS-ROCHE/
RTS1SS8
September 18, 2015
Clothes hangers with the logo of Roche are seen in the new 'Bau 1' office building of Swiss drugmaker...
Basel, Switzerland
Clothes hangers with the logo of Roche are seen in the new 'Bau 1' office building of Swiss drugmaker...
Clothes hangers with the logo of Roche are seen in the new 'Bau 1' office building of Swiss drugmaker Roche in Basel, Switzerland September 18, 2015. REUTERS/Ruben Sprich
SWISS-ROCHE/
RTS1SFB
September 18, 2015
Clothes hangers with the logo of Roche are seen in the new 'Bau 1' office building of Swiss drugmaker...
Basel, Switzerland
Clothes hangers with the logo of Roche are seen in the new 'Bau 1' office building of Swiss drugmaker...
Clothes hangers with the logo of Roche are seen in the new 'Bau 1' office building of Swiss drugmaker Roche in Basel, Switzerland September 18, 2015. REUTERS/Ruben Sprich
SWISS-ROCHE/
RTS1Q5B
September 18, 2015
The new 'Bau 1' office building of Swiss drugmaker Roche in Basel, Switzerland September 18, 2015. The...
Basel, Switzerland
The new 'Bau 1' office building of Swiss drugmaker Roche in Basel
The new 'Bau 1' office building of Swiss drugmaker Roche in Basel, Switzerland September 18, 2015. The 178 metre high 'Bau 1' is the highest building in Switzerland. REUTERS/Ruben Sprich
SWISS-ROCHE/
RTS1Q0U
September 18, 2015
An overview of the city of Basel is seen from the new 'Bau 1' office building of Swiss drugmaker Roche...
Basel, Switzerland
An overview of the city of Basel is seen from the new 'Bau 1' office building of Swiss drugmaker Roche...
An overview of the city of Basel is seen from the new 'Bau 1' office building of Swiss drugmaker Roche in Basel, Switzerland September 18, 2015. The 178 metre high 'Bau 1' is the highest building in Switzerland, according to local media. REUTERS/Ruben Sprich
SWISS-ROCHE/
RTS1Q0Q
September 18, 2015
Staff walk on stairs in the new 'Bau 1' office building of Swiss drugmaker Roche in Basel, Switzerland...
Basel, Switzerland
Staff walk on stairs in the new 'Bau 1' office building of Swiss drugmaker Roche in Basel
Staff walk on stairs in the new 'Bau 1' office building of Swiss drugmaker Roche in Basel, Switzerland September 18, 2015. The 178 metre high 'Bau 1' is the highest building in Switzerland, according to local media. REUTERS/Ruben Sprich
SWISS-ROCHE/
RTS1PX1
September 18, 2015
Journalists look out on the top floor in the new 'Bau 1' office building of Swiss drugmaker Roche in...
Basel, Switzerland
Journalists look out on the top floor in the new 'Bau 1' office building of Swiss drugmaker Roche in...
Journalists look out on the top floor in the new 'Bau 1' office building of Swiss drugmaker Roche in Basel, Switzerland September 18, 2015. The 178 metre high 'Bau 1' is the highest building in Switzerland. REUTERS/Ruben Sprich
SWISS-ROCHE/
RTS1PWY
September 18, 2015
A view of the new 'Bau 1' office building of Swiss drugmaker Roche in Basel September 18, 2015. The 178...
Basel, Switzerland
View of the new 'Bau 1' office building of Swiss drugmaker Roche in Basel
A view of the new 'Bau 1' office building of Swiss drugmaker Roche in Basel September 18, 2015. The 178 metre high 'Bau 1' is the highest building in Switzerland. REUTERS/Ruben Sprich
SWISS-ROCHE/
RTS1PWP
September 18, 2015
Roche CEO Severin Schwan speaks to media during a news conference for the opening of the new 'Bau 1'...
Basel, Switzerland
Roche CEO Schwan speaks to media during a news conference for the opening of the new 'Bau 1' building...
Roche CEO Severin Schwan speaks to media during a news conference for the opening of the new 'Bau 1' building of Swiss drugmaker Roche in Basel September 18, 2015. The 178 metre high Bau 1 is the highest building in Switzerland. REUTERS/Ruben Sprich
SWISS-ROCHE/
RTS1PWI
September 18, 2015
Roche CEO Severin Schwan (R) and architect Jacques Herzog attend a news conference for the opening of...
Basel, Switzerland
Roche CEO Schwan and architect Herzog attend a news conference for the opening of the new 'Bau 1' building...
Roche CEO Severin Schwan (R) and architect Jacques Herzog attend a news conference for the opening of the new 'Bau 1' building of Swiss drugmaker Roche in Basel September 18, 2015. The 178 metre high Bau 1 is the highest building in Switzerland. REUTERS/Ruben Sprich
CHUGAI PHARM-ROCHE/SHARES
RTR42RJK
August 18, 2014
A signboard of Chugai Pharmaceutical Co is seen at the company factory in Tokyo August 18, 2014. Chugai...
Tokyo, Japan
Signboard of Chugai Pharmaceutical Co is seen at the company factory in Tokyo
A signboard of Chugai Pharmaceutical Co is seen at the company factory in Tokyo August 18, 2014. Chugai Pharmaceutical Co Ltd shares rose 21 percent to a record high following a media report that Roche Holding AG is in talks to buy the almost 40 percent stake in the Japanese firm that it doesn't already own for about $10 billion. REUTERS/Toru Hanai (JAPAN - Tags: BUSINESS)
CHUGAI PHARM-ROCHE/SHARES
RTR42RJI
August 18, 2014
A signboard of Chugai Pharmaceutical Co is seen at the company factory in Tokyo August 18, 2014. Chugai...
Tokyo, Japan
Signboard of Chugai Pharmaceutical Co is seen at the company factory in Tokyo
A signboard of Chugai Pharmaceutical Co is seen at the company factory in Tokyo August 18, 2014. Chugai Pharmaceutical Co Ltd shares rose 21 percent to a record high following a media report that Roche Holding AG is in talks to buy the almost 40 percent stake in the Japanese firm that it doesn't already own for about $10 billion. REUTERS/Toru Hanai (JAPAN - Tags: BUSINESS LOGO)
CHUGAI PHARM-ROCHE/SHARES
RTR42RJ9
August 18, 2014
Signboards of Chugai Pharmaceutical Co are seen at the company factory in Tokyo August 18, 2014. Chugai...
Tokyo, Japan
Signboards of Chugai Pharmaceutical Co are seen at the company factory in Tokyo
Signboards of Chugai Pharmaceutical Co are seen at the company factory in Tokyo August 18, 2014. Chugai Pharmaceutical Co Ltd shares rose 21 percent to a record high following a media report that Roche Holding AG is in talks to buy the almost 40 percent stake in the Japanese firm that it doesn't already own for about $10 billion. REUTERS/Toru Hanai (JAPAN - Tags: BUSINESS)
CHUGAI PHARM-ROCHE/SHARES
RTR42RJ7
August 18, 2014
A man walks past a signboard of Chugai Pharmaceutical Co outside the company factory in Tokyo August...
Tokyo, Japan
Man walks past a signboard of Chugai Pharmaceutical Co outside the company factory in Tokyo
A man walks past a signboard of Chugai Pharmaceutical Co outside the company factory in Tokyo August 18, 2014. Chugai Pharmaceutical Co Ltd shares rose 21 percent to a record high following a media report that Roche Holding AG is in talks to buy the almost 40 percent stake in the Japanese firm that it doesn't already own for about $10 billion. REUTERS/Toru Hanai (JAPAN - Tags: BUSINESS)
ROCHE/CHINA/FRAUD
RTR3QE54
May 22, 2014
The logo of Swiss pharmaceutical company Roche is seen outside the Shanghai Roche Pharmaceutical Co....
Shanghai, China
The logo of Swiss pharmaceutical company Roche is seen outside the Shanghai Roche Pharmaceutical Co....
The logo of Swiss pharmaceutical company Roche is seen outside the Shanghai Roche Pharmaceutical Co. Ltd. headquarters in Shanghai May 22, 2014. Swiss drugmaker Roche Holding AG said it had been visited by a unit of China's anti-trust regulator. It was not immediately clear what was behind the visit. REUTERS/Aly Song (CHINA - Tags: POLITICS BUSINESS HEALTH)
ROCHE/CHINA/FRAUD
RTR3QE4D
May 22, 2014
The logo of Shanghai Roche Pharmaceutical Co. Ltd. is seen outside their headquarters in Shanghai May...
Shanghai, China
The logo of Shanghai Roche Pharmaceutical Co. Ltd. is seen outside their headquarters in Shanghai
The logo of Shanghai Roche Pharmaceutical Co. Ltd. is seen outside their headquarters in Shanghai May 22, 2014. Swiss drugmaker Roche Holding AG said it had been visited by a unit of China's anti-trust regulator, apart of a widening crackdown on corruption and high prices in the country's pharmaceutical sector. It was not immediately clear what was behind the visit. REUTERS/Aly Song (CHINA - Tags: BUSINESS HEALTH POLITICS LOGO)
Health
Health
New Drug Aids Cancer Treatment - 27 Sep 2013
18 PICTURES
ROCHE/
RTXVBQW
December 02, 2010
Dr. Severin Schwan, CEO of Roche Holding AG, speaks to the Boston College Chief Executives Club of Boston...
Boston, UNITED STATES
Dr. Schwan, CEO of Roche Holding AG, speaks to the Boston College Chief Executives Club of Boston luncheon...
Dr. Severin Schwan, CEO of Roche Holding AG, speaks to the Boston College Chief Executives Club of Boston luncheon in Boston, Massachusetts December 2, 2010. REUTERS/Brian Snyder (UNITED STATES - Tags: BUSINESS HEALTH)
ROCHE/
RTXVBQS
December 02, 2010
Dr. Severin Schwan, CEO of Roche Holding AG, speaks to the Boston College Chief Executives Club of Boston...
Boston, UNITED STATES
Dr. Schwan, CEO of Roche Holding AG, speaks to the Boston College Chief Executives Club of Boston luncheon...
Dr. Severin Schwan, CEO of Roche Holding AG, speaks to the Boston College Chief Executives Club of Boston luncheon in Boston, Massachusetts December 2, 2010. REUTERS/Brian Snyder (UNITED STATES - Tags: BUSINESS HEALTH)
ROCHE/
RTXVBPX
December 02, 2010
Dr. Severin Schwan, CEO of Roche Holding AG, listens as he is introduced for a presentation to the Boston...
Boston, UNITED STATES
Dr. Schwan, CEO of Roche Holding AG, listens as he is introduced for a presentation to the Boston College...
Dr. Severin Schwan, CEO of Roche Holding AG, listens as he is introduced for a presentation to the Boston College Chief Executives Club of Boston luncheon in Boston, Massachusetts December 2, 2010. REUTERS/Brian Snyder (UNITED STATES - Tags: BUSINESS HEALTH HEADSHOT)
ROCHE/
RTXVBPT
December 02, 2010
Dr. Severin Schwan, CEO of Roche Holding AG, watches a video during his presentation to the Boston College...
Boston, UNITED STATES
Dr. Schwan, CEO of Roche Holding AG, watches a video during his presentation to the Boston College Chief...
Dr. Severin Schwan, CEO of Roche Holding AG, watches a video during his presentation to the Boston College Chief Executives Club of Boston luncheon in Boston, Massachusetts December 2, 2010. REUTERS/Brian Snyder (UNITED STATES - Tags: BUSINESS HEALTH)
ROCHE/
RTXVBPK
December 02, 2010
Dr. Severin Schwan, CEO of Roche Holding AG, speaks to the Boston College Chief Executives Club of Boston...
Boston, UNITED STATES
Dr. Schwan, CEO of Roche Holding AG, speaks to the Boston College Chief Executives Club of Boston luncheon...
Dr. Severin Schwan, CEO of Roche Holding AG, speaks to the Boston College Chief Executives Club of Boston luncheon in Boston, Massachusetts December 2, 2010. REUTERS/Brian Snyder (UNITED STATES - Tags: BUSINESS HEALTH)
ROCHE/
RTXVBPB
December 02, 2010
Dr. Severin Schwan, CEO of Roche Holding AG, watches a video during his presentation to the Boston College...
Boston, UNITED STATES
Dr. Schwan, CEO of Roche Holding AG, watches a video during his presentation to the Boston College Chief...
Dr. Severin Schwan, CEO of Roche Holding AG, watches a video during his presentation to the Boston College Chief Executives Club of Boston luncheon in Boston, Massachusetts December 2, 2010. REUTERS/Brian Snyder (UNITED STATES - Tags: BUSINESS HEALTH)
ROCHE/
RTXVBP2
December 02, 2010
Dr. Severin Schwan, CEO of Roche Holding AG, speaks to the Boston College Chief Executives Club of Boston...
Boston, UNITED STATES
Dr. Schwan, CEO of Roche Holding AG, speaks to the Boston College Chief Executives Club of Boston luncheon...
Dr. Severin Schwan, CEO of Roche Holding AG, speaks to the Boston College Chief Executives Club of Boston luncheon in Boston, Massachusetts December 2, 2010. REUTERS/Brian Snyder (UNITED STATES - Tags: BUSINESS HEALTH HEADSHOT)
ROCHE/
RTXUQGK
November 17, 2010
People enter a factory of Swiss drugmaker Roche in Burgdorf near Bern November 17, 2010. Roche Holding...
Burgdorf, Switzerland
People enter a factory of Swiss drugmaker Roche in Burgdorf near Bern
People enter a factory of Swiss drugmaker Roche in Burgdorf near Bern November 17, 2010. Roche Holding AG announced plans to slash costs on Wednesday, joining Big Pharma rivals with a wide-ranging restructuring program as it grapples with recent product setbacks and mounting pressure on prices. The group will slash 4,800 jobs worldwide, or about six percent of its current workforce of around 82,000, over the next two years, with the largest reductions planned in sales and marketing and in manufacturing. REUTERS/Pascal Lauener (SWITZERLAND - Tags: BUSINESS HEALTH)
ROCHE/
RTXUQGJ
November 17, 2010
People enter a factory of Swiss drugmaker Roche in Burgdorf near Bern November 17, 2010. Roche Holding...
Burgdorf, Switzerland
People enter a factory of Swiss drugmaker Roche in Burgdorf near Bern
People enter a factory of Swiss drugmaker Roche in Burgdorf near Bern November 17, 2010. Roche Holding AG announced plans to slash costs on Wednesday, joining Big Pharma rivals with a wide-ranging restructuring program as it grapples with recent product setbacks and mounting pressure on prices. The group will slash 4,800 jobs worldwide, or about six percent of its current workforce of around 82,000, over the next two years, with the largest reductions planned in sales and marketing and in manufacturing. REUTERS/Pascal Lauener (SWITZERLAND - Tags: BUSINESS HEALTH)
ROCHE/
RTXUQGH
November 17, 2010
The logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf near Bern November 17, 2010. Roche...
Burgdorf, Switzerland
The logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf
The logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf near Bern November 17, 2010. Roche Holding AG announced plans to slash costs on Wednesday, joining Big Pharma rivals with a wide-ranging restructuring program as it grapples with recent product setbacks and mounting pressure on prices. The group will slash 4,800 jobs worldwide, or about six percent of its current workforce of around 82,000, over the next two years, with the largest reductions planned in sales and marketing and in manufacturing. REUTERS/Pascal Lauener (SWITZERLAND - Tags: BUSINESS HEALTH)
ROCHE/
RTXUQGB
November 17, 2010
The logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf near Bern November 17, 2010. Roche...
Burgdorf, Switzerland
The logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf
The logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf near Bern November 17, 2010. Roche Holding AG announced plans to slash costs on Wednesday, joining Big Pharma rivals with a wide-ranging restructuring program as it grapples with recent product setbacks and mounting pressure on prices. The group will slash 4,800 jobs worldwide, or about six percent of its current workforce of around 82,000, over the next two years, with the largest reductions planned in sales and marketing and in manufacturing. REUTERS/Pascal Lauener (SWITZERLAND - Tags: BUSINESS HEALTH)
ROCHE/
RTXUQG9
November 17, 2010
The logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf near Bern November 17, 2010. Roche...
Burgdorf, Switzerland
The logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf
The logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf near Bern November 17, 2010. Roche Holding AG announced plans to slash costs on Wednesday, joining Big Pharma rivals with a wide-ranging restructuring program as it grapples with recent product setbacks and mounting pressure on prices. The group will slash 4,800 jobs worldwide, or about six percent of its current workforce of around 82,000, over the next two years, with the largest reductions planned in sales and marketing and in manufacturing. REUTERS/Pascal Lauener (SWITZERLAND - Tags: BUSINESS HEALTH)
ROCHE/
RTXUQG5
November 17, 2010
The logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf near Bern November 17, 2010. Roche...
Burgdorf, Switzerland
The logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf
The logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf near Bern November 17, 2010. Roche Holding AG announced plans to slash costs on Wednesday, joining Big Pharma rivals with a wide-ranging restructuring program as it grapples with recent product setbacks and mounting pressure on prices. The group will slash 4,800 jobs worldwide, or about six percent of its current workforce of around 82,000, over the next two years, with the largest reductions planned in sales and marketing and in manufacturing. REUTERS/Pascal Lauener (SWITZERLAND - Tags: BUSINESS HEALTH)
ROCHE/
RTXUQG4
November 17, 2010
The logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf near Bern November 17, 2010. Roche...
Burgdorf, Switzerland
The logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf
The logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf near Bern November 17, 2010. Roche Holding AG announced plans to slash costs on Wednesday, joining Big Pharma rivals with a wide-ranging restructuring program as it grapples with recent product setbacks and mounting pressure on prices. The group will slash 4,800 jobs worldwide, or about six percent of its current workforce of around 82,000, over the next two years, with the largest reductions planned in sales and marketing and in manufacturing. REUTERS/Pascal Lauener (SWITZERLAND - Tags: BUSINESS HEALTH IMAGES OF THE DAY)
ROCHE/
RTR29S7U
February 03, 2010
Swiss pharmaceutical company Roche CEO Severin Schwan attends the company's annual news conference in...
Basel, Switzerland
Roche CEO Schwan attends media during annual news conference in Basel
Swiss pharmaceutical company Roche CEO Severin Schwan attends the company's annual news conference in Basel February 3, 2010. Roche Holding AG missed full-year profit forecasts due to disappointing sales of key cancer drugs and gave a lacklustre outlook for 2010, pointing up the wider challenges facing global drugmakers.
REUTERS/Christian Hartmann (SWITZERLAND - Tags: BUSINESS HEALTH IMAGES OF THE DAY)
ROCHE/
RTR25Y6X
July 23, 2009
A general view shows the plant of Swiss pharmaceutical company Roche and the Rhine River in Basel July...
Basel, Switzerland
A general view shows the plant of Swiss pharmaceutical company Roche and the Rhine River in Basel
A general view shows the plant of Swiss pharmaceutical company Roche and the Rhine River in Basel July 20, 2009. Swiss drugmaker Roche gave a bullish forecast for the next two years after its $47 billion acquisition of Genentech and said it would expand capacity for H1N1 flu drug Tamiflu. Picture taken July 20. REUTERS/Arnd Wiegmann (SWITZERLAND BUSINESS HEALTH)
ROCHE/
RTR25Y6V
July 23, 2009
The logo of Swiss pharmaceutical company Roche is seen at an office building at the company's plant in...
Basel, Switzerland
The logo of Swiss pharmaceutical company Roche is seen at an office building at the company's plant in...
The logo of Swiss pharmaceutical company Roche is seen at an office building at the company's plant in Basel July 20, 2009. Swiss drugmaker Roche gave a bullish forecast for the next two years after its $47 billion acquisition of Genentech and said it would expand capacity for H1N1 flu drug Tamiflu. Picture taken July 20.
REUTERS/Arnd Wiegmann (SWITZERLAND BUSINESS HEALTH)
FLU-DRUGMAKERS/
RTXEHRG
April 28, 2009
Packs of the anti-viral drug Tamiflu are pictured in a drawer at a pharmacy near Bonn April 28, 2009....
BAD HONNEF, Germany
Packs of the anti-viral drug Tamiflu are pictured in a drawer at a pharmacy near Bonn
Packs of the anti-viral drug Tamiflu are pictured in a drawer at a pharmacy near Bonn April 28, 2009. Swiss drugmaker Roche Holding AG is working on scaling up production of Tamiflu, a drug which has been shown to work against the new flu strain that has killed 149 people in Mexico. REUTERS/Wolfgang Rattay (GERMANY SOCIETY BUSINESS HEALTH)
FLU-DRUGMAKERS/
RTXEHR7
April 28, 2009
Packs of the anti-viral drug Tamiflu are pictured in a pharmacy near Bonn April 28, 2009. Swiss drugmaker...
BAD HONNEF, Germany
Packs of the anti-viral drug Tamiflu are pictured in a pharmacy near Bonn
Packs of the anti-viral drug Tamiflu are pictured in a pharmacy near Bonn April 28, 2009. Swiss drugmaker Roche Holding AG is working on scaling up production of Tamiflu, a drug which has been shown to work against the new flu strain that has killed 149 people in Mexico. REUTERS/Wolfgang Rattay (GERMANY SOCIETY BUSINESS HEALTH)
FLU-DRUGMAKERS/
RTXEHQX
April 28, 2009
A pack of the anti-viral drug Tamiflu is held up to be photographed in a pharmacy near Bonn April 28,...
BAD HONNEF, Germany
A pack of the anti-viral drug Tamiflu is held up to be photographed in a pharmacy near Bonn
A pack of the anti-viral drug Tamiflu is held up to be photographed in a pharmacy near Bonn April 28, 2009. Swiss drugmaker Roche Holding AG is working on scaling up production of Tamiflu, a drug which has been shown to work against the new flu strain that has killed 149 people in Mexico. REUTERS/Wolfgang Rattay (GERMANY SOCIETY BUSINESS HEALTH)
FLU-DRUGMAKERS/
RTXEHQQ
April 28, 2009
A pack of the anti-viral drug Tamiflu is held up to be photographed in a pharmacy near Bonn April 28,...
BAD HONNEF, Germany
A pack of the anti-viral drug Tamiflu is held up to be photographed in a pharmacy near Bonn
A pack of the anti-viral drug Tamiflu is held up to be photographed in a pharmacy near Bonn April 28, 2009. Swiss drugmaker Roche Holding AG is working on scaling up production of Tamiflu, a drug which has been shown to work against the new flu strain that has killed 149 people in Mexico. REUTERS/Wolfgang Rattay (GERMANY SOCIETY BUSINESS HEALTH)
FLU/
RTXEHCY
April 28, 2009
Tamiflu tablets are pictured at Health Consult in Vienna April 28, 2009. Swiss drugmaker Roche Holding...
Vienna, Austria
Tamiflu tablets are pictured at Health Consult in Vienna
Tamiflu tablets are pictured at Health Consult in Vienna April 28, 2009. Swiss drugmaker Roche Holding AG is working on scaling up production of Tamiflu, a drug which has been shown to work against the swine flu that has killed 149 people in Mexico. REUTERS/Leonhard Foeger (AUSTRIA HEALTH SOCIETY)
FLU/
RTXEHCW
April 28, 2009
Tamiflu tablets are pictured at Health Consult in Vienna April 28, 2009. Swiss drugmaker Roche Holding...
Vienna, Austria
Tamiflu tablets are pictured at Health Consult in Vienna
Tamiflu tablets are pictured at Health Consult in Vienna April 28, 2009. Swiss drugmaker Roche Holding AG is working on scaling up production of Tamiflu, a drug which has been shown to work against the swine flu that has killed 149 people in Mexico. REUTERS/Leonhard Foeger (AUSTRIA HEALTH SOCIETY)
FLU/
RTXEHCV
April 28, 2009
Tamiflu tablets are pictured at Health Consult in Vienna April 28, 2009. Swiss drugmaker Roche Holding...
Vienna, Austria
Tamiflu tablets are pictured at Health Consult in Vienna
Tamiflu tablets are pictured at Health Consult in Vienna April 28, 2009. Swiss drugmaker Roche Holding AG is working on scaling up production of Tamiflu, a drug which has been shown to work against the swine flu that has killed 149 people in Mexico. REUTERS/Leonhard Foeger (AUSTRIA HEALTH SOCIETY)
FLU/
RTXEHCS
April 28, 2009
Tamiflu tablets are pictured at Health Consult in Vienna April 28, 2009. Swiss drugmaker Roche Holding...
Vienna, Austria
Tamiflu tablets are pictured at Health Consult in Vienna
Tamiflu tablets are pictured at Health Consult in Vienna April 28, 2009. Swiss drugmaker Roche Holding AG is working on scaling up production of Tamiflu, a drug which has been shown to work against the swine flu that has killed 149 people in Mexico. REUTERS/Leonhard Foeger (AUSTRIA HEALTH SOCIETY)
FLU/
RTXEH7Q
April 28, 2009
Anti-viral drug Tamiflu is pictured in a pharmacy at Duesseldorf's airport April 28, 2009. Swiss drugmaker...
Duesseldorf, Germany
Anti-viral drug Tamiflu is pictured in a pharmacy at Duesseldorf's airport
Anti-viral drug Tamiflu is pictured in a pharmacy at Duesseldorf's airport April 28, 2009. Swiss drugmaker Roche Holding AG is working on scaling up production of Tamiflu, a drug which has been shown to work against the swine flu that has killed 149 people in Mexico. REUTERS/Wolfgang Rattay (GERMANY SOCIETY HEALTH)
FLU/
RTXEH7M
April 28, 2009
Anti-viral drug Tamiflu is pictured in a pharmacy at Duesseldorf's airport April 28, 2009. Swiss drugmaker...
Duesseldorf, Germany
Anti-viral drug Tamiflu is pictured in a pharmacy at Duesseldorf's airport
Anti-viral drug Tamiflu is pictured in a pharmacy at Duesseldorf's airport April 28, 2009. Swiss drugmaker Roche Holding AG is working on scaling up production of Tamiflu, a drug which has been shown to work against the swine flu that has killed 149 people in Mexico. REUTERS/Wolfgang Rattay (GERMANY SOCIETY HEALTH)
FLU/
RTXEH7J
April 28, 2009
Anti-viral drug Tamiflu is pictured in a pharmacy at Duesseldorf's airport April 28, 2009. Swiss drugmaker...
Duesseldorf, Germany
Anti-viral drug Tamiflu is pictured in a pharmacy at Duesseldorf's airport
Anti-viral drug Tamiflu is pictured in a pharmacy at Duesseldorf's airport April 28, 2009. Swiss drugmaker Roche Holding AG is working on scaling up production of Tamiflu, a drug which has been shown to work against the swine flu that has killed 149 people in Mexico. REUTERS/Wolfgang Rattay (GERMANY SOCIETY HEALTH)
ROCHE/
RTXBB20
February 06, 2009
Bill Burns, CEO Division of Roche Pharmaceuticals, speaks during an interview in New York February 6,...
New York, UNITED STATES
Bill Burns, CEO Division of Roche Pharmaceuticals, speaks during an interview in New York
Bill Burns, CEO Division of Roche Pharmaceuticals, speaks during an interview in New York February 6, 2009. Roche Holding AG's chief executive Severin Schwan said on Friday the company expects to file its tender offer for Genentech Inc shares next week, and the Swiss drugmaker projected high hopes for its own medicines for arthritis, cholesterol and diabetes. REUTERS/Shannon Stapleton (UNITED STATES)
ROCHE/
RTXB7RD
February 04, 2009
The logo of Swiss pharmaceutical company Roche is pictured on the company's headquarters in Basel February...
Basel, Switzerland
The logo of Swiss pharmaceutical company Roche is pictured on the company's headquarters in Basel
The logo of Swiss pharmaceutical company Roche is pictured on the company's headquarters in Basel February 4, 2009. REUTERS/Christian Hartmann (SWITZERLAND)
ROCHE/
RTXB7R1
February 04, 2009
People are reflected in a window (R) as they walk past the headquarters of Swiss pharmaceutical company...
Basel, Switzerland
People are reflected in a window as they walk past the headquarters of Swiss pharmaceutical company Roche...
People are reflected in a window (R) as they walk past the headquarters of Swiss pharmaceutical company Roche in Basel February 4, 2009. REUTERS/Christian Hartmann (SWITZERLAND)
ROCHE/GENENTECH
RTR20EBB
July 21, 2008
A logo is pictured on Swiss drug makers Roche plant in Kaiseraugst near Basel July 21, 2008. Roche Holding...
KAISERAUGST, Switzerland
A logo is pictured on Swiss drugmakers Roche plant in Kaiseraugst
A logo is pictured on Swiss drug makers Roche plant in Kaiseraugst near Basel July 21, 2008. Roche Holding AG offered on Monday to acquire all outstanding shares in its U.S. partner Genentech Inc for $43.7 billion in cash to reinforce its position in cancer medicines. REUTERS/Christian Hartmann (SWITZERLAND)
ROCHE/GENENTECH
RTR20EBA
July 21, 2008
A logo is pictured on Swiss drug makers Roche plant in Kaiseraugst near Basel July 21, 2008. Roche Holding...
KAISERAUGST, Switzerland
A logo is pictured on Swiss drugmakers Roche plant in Kaiseraugst
A logo is pictured on Swiss drug makers Roche plant in Kaiseraugst near Basel July 21, 2008. Roche Holding AG offered on Monday to acquire all outstanding shares in its U.S. partner Genentech Inc for $43.7 billion in cash to reinforce its position in cancer medicines. REUTERS/Christian Hartmann (SWITZERLAND)
ROCHE/GENENTECH
RTR20E5Q
July 21, 2008
A general view shows the headquarter of Swiss drugmaker Roche in Basel July 21, 2008. Roche Holding AG...
Basel, Switzerland
A general view shows the headquarter of Swiss drugmaker Roche Holding AG in Basel
A general view shows the headquarter of Swiss drugmaker Roche in Basel July 21, 2008. Roche Holding AG offered on Monday to acquire all outstanding shares in its U.S. partner Genentech Inc for $43.7 billion in cash to reinforce its position in cancer medicines. REUTERS/Christian Hartmann (SWITZERLAND)
ROCHE/GENENTECH
RTR20E5P
July 21, 2008
A general view shows the headquarter of Swiss drugmaker Roche in Basel July 21, 2008. Roche Holding AG...
Basel, Switzerland
A general view shows the headquarter of Swiss drugmaker Roche Holding AG in Basel
A general view shows the headquarter of Swiss drugmaker Roche in Basel July 21, 2008. Roche Holding AG offered on Monday to acquire all outstanding shares in its U.S. partner Genentech Inc for $43.7 billion in cash to reinforce its position in cancer medicines. REUTERS/Christian Hartmann (SWITZERLAND)
ROCHE/GENENTECH
RTR20EB3
July 20, 2008
A logo is pictured on Swiss drug makers Roche plant in Kaiseraugst near Basel July 21, 2008. Roche Holding...
KAISERAUGST, Switzerland
A logo is pictured on Swiss drugmakers Roche plant in Kaiseraugst
A logo is pictured on Swiss drug makers Roche plant in Kaiseraugst near Basel July 21, 2008. Roche Holding AG offered on Monday to acquire all outstanding shares in its U.S. partner Genentech Inc for $43.7 billion in cash to reinforce its position in cancer medicines. REUTERS/Christian Hartmann (SWITZERLAND)
SWITZERLAND/
RTR1XV5O
March 04, 2008
The logo of Swiss pharmaceutical company Roche's is seen during the general annual shareholders meeting...
Basel, Switzerland
The logo of Swiss pharmaceutical company Roche's is seen during the annual shareholders meeting of the...
The logo of Swiss pharmaceutical company Roche's is seen during the general annual shareholders meeting of the company in Basel, March 4, 2008. REUTERS/Vincent Kessler (SWITZERLAND)
HEALTH-SUMMIT/ SPEAKERS
RTX9JG
November 12, 2007
Franz Humer, Chairman and Chief Executive of Roche Holding AG, speaks at the Reuters Health Summit in...
New York, UNITED STATES
Chairman of Roche Holding AG Franz Humer speaks at the Reuters Health Summit in New York
Franz Humer, Chairman and Chief Executive of Roche Holding AG, speaks at the Reuters Health Summit in New York November 12, 2007. REUTERS/Brendan McDermid (UNITED STATES)
HEALTH-SUMMIT/ SPEAKERS
RTX9JF
November 12, 2007
Franz Humer, Chairman and Chief Executive of Roche Holding AG, speaks at the Reuters Health Summit in...
New York, UNITED STATES
Chairman of Roche Holding AG Franz Humer speaks at the Reuters Health Summit in New York
Franz Humer, Chairman and Chief Executive of Roche Holding AG, speaks at the Reuters Health Summit in New York November 12, 2007. REUTERS/Brendan McDermid (UNITED STATES)
SUMMIT-HEALTH/
RTX9JD
November 12, 2007
Franz Humer, Chairman and Chief Executive of Roche Holding AG, speaks at the Reuters Health Summit in...
New York, UNITED STATES
Chairman of Roche Holding AG Franz Humer speaks at the Reuters Health Summit in New York
Franz Humer, Chairman and Chief Executive of Roche Holding AG, speaks at the Reuters Health Summit in New York November 12, 2007. REUTERS/Brendan McDermid (UNITED STATES)
HEALTH BRITAIN HERCEPTIN
RTR1E8GD
June 09, 2006
A pharmacologist injects a phial of concentrated Herceptin in London June 9, 2006. Herceptin, the drug...
London, United Kingdom
Pharmacologist injects phial of concentrated Herceptin in London
A pharmacologist injects a phial of concentrated Herceptin in London June 9, 2006. Herceptin, the drug at the centre of protests over healthcare rationing, should be used in early breast cancer and be paid for by the state health service, Britain's cost-effectiveness watchdog said on Friday. REUTERS/Luke MacGregor (BRITAIN)
HEALTH BRITAIN HERCEPTIN
RTR1E8G6
June 09, 2006
A phial and pack of herceptin are seen in London June 9, 2006. Herceptin, the drug at the centre of protests...
London, United Kingdom
Phial and pack of Herceptin are seen in London
A phial and pack of herceptin are seen in London June 9, 2006. Herceptin, the drug at the centre of protests over healthcare rationing, should be used in early breast cancer and be paid for by the state health service, Britain's cost-effectiveness watchdog said on Friday. REUTERS/Luke MacGregor (BRITAIN)
HEALTH BRITAIN HERCEPTIN
RTR1E8FF
June 09, 2006
A pharmacologist injects a phial of concentrated herceptin with water to dilute for use, in London June...
London, United Kingdom
Pharmacologist injects phial of concentrated herceptin with water to dilute for use in London
A pharmacologist injects a phial of concentrated herceptin with water to dilute for use, in London June 9, 2006. Herceptin, the drug at the centre of protests over healthcare rationing, should be used in early breast cancer and be paid for by the NHS, the cost-effectiveness watchdog said on Friday. REUTERS/Luke MacGregor (BRITAIN)
Sort by
Display
Items per page
Page
of 2